Evaluation of Programmed Death - Ligand 1 (Pd-L1) Expression in Head and Neck Squamous Cell Carcinoma

BACKGROUND & OBJECTIVE: Head and Neck Squamous Cell Carcinoma (HNSCC) is a highly frequent malignancy worldwide and is also the leading cause of death. The prognosis for individuals with HNSCC remains dismal, with a five-year survival rate of less than 50%. The novel anti-PD-L1 immunotherapy is...

Descripción completa

Detalles Bibliográficos
Autores principales: Unnikrishnan, Aarya, Basavaraj, Vijaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Society of Pathology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439758/
https://www.ncbi.nlm.nih.gov/pubmed/37600575
http://dx.doi.org/10.30699/ijp.2023.1988955.3057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439758/
https://www.ncbi.nlm.nih.gov/pubmed/37600575
http://dx.doi.org/10.30699/ijp.2023.1988955.3057

Ejemplares similares